Furthermore, insights into the normal functions and signaling interactions of the CYLD gene product indicate that CYLD interferes with NF-κB-, JNK-, WNT-, and p38MAPK signaling to limit inflammation and cancer depending upon the tissue-/cell-type or in vivo model system [10]. Here, CYLD is linked to cancer.